MARKET

BCRX

BCRX

BioCryst Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.780
-0.050
-1.77%
After Hours: 2.850 +0.07 +2.52% 19:15 01/17 EST
OPEN
2.870
PREV CLOSE
2.830
HIGH
2.880
LOW
2.710
VOLUME
4.87M
TURNOVER
--
52 WEEK HIGH
9.95
52 WEEK LOW
1.380
MARKET CAP
428.28M
P/E (TTM)
-2.2918
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BCRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BCRX News

  • BioCryst Strengthens Commercial Rare Disease Leadership
  • GlobeNewswire.3d ago
  • Is the Options Market Predicting a Spike in BioCryst (BCRX) Stock?
  • Zacks.01/10 13:54
  • Apellis Pharmaceuticals: PEGASUS Trial Confirms Pegcetacoplan's Efficacy Over Soliris In PNH Patients
  • Seeking Alpha - Article.01/09 17:46
  • BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
  • GlobeNewswire.01/06 12:00

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About BCRX

BioCryst Pharmaceuticals, Inc. is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on the treatment of rare diseases. It uses X-ray crystallography, computer modeling of molecular structures and chemistry techniques to focus on the three-dimensional molecular structure and active site characteristics of the enzymes that control cellular biology. The Company's drug candidates include RAPIVAB, RAPIACTA, ALPIVAB, PERAMIFLU, Avoralstat, BCX7353, other second generation hereditary angioedema (HAE) compounds, Galidesivir and Forodesine. Its product RAPIVAB contains peramivir. ALPIVAB is an intravenous neuraminidase inhibitor. Galidesivir is a broad-spectrum antiviral (BSAV) research program developed for the treatment of hemorrhagic fever viruses. Forodesine is a Purine Nucleoside Phosphorylase (PNP) inhibitor in development by Mundipharma as a treatment for cancer.
More

Webull offers BioCryst Pharmaceuticals, Inc. (BCRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.